Evidence map›Paper›PMID 37457727›Full record

ArticleFrontiers in immunology2023

Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress.

Beatriz Martín-Adrados, Stefanie K Wculek, Sergio Fernández-Bravo, Raúl Torres-Ruiz, Ana Valle-Noguera, Maria José Gomez-Sánchez, José Carlos Hernández-Walias, Frederico Moraes Ferreira, Ana María Corraliza, David Sancho and 13 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 3 countries.

Beatriz Martín-AdradosDepartment of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
Stefanie K WculekImmunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Sergio Fernández-BravoDepartment of Allergy and Immunology, IIS-Fundación Jiménez Díaz, Universidad Autónoma of Madrid, Madrid, Spain.
Raúl Torres-RuizMolecular Cytogenetics & Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro, Madrid, Spain.
Ana Valle-NogueraDepartment of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
Maria José Gomez-SánchezDepartment of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
José Carlos Hernández-WaliasDepartment of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
Frederico Moraes FerreiraLIM50, Division of Pathology, University of São Paulo School of Medicine, São Paulo, SP, Brazil.
Ana María CorralizaDepartment of Gastroenterology, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Hospital Clinic of Barcelona, Centro de Investigación Biomédica en Red-Enfermedades Hepáticas y Digestivas (CIBER-EHD), Barcelona, Spain.
David SanchoImmunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Vanesa EstebanDepartment of Allergy and Immunology, IIS-Fundación Jiménez Díaz, Universidad Autónoma of Madrid, Madrid, Spain.
Sandra Rodriguez-PeralesMolecular Cytogenetics & Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro, Madrid, Spain.
Aránzazu Cruz-AdaliaDepartment of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
Helder I NakayaDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo (USP), Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Azucena SalasDepartment of Gastroenterology, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Hospital Clinic of Barcelona, Centro de Investigación Biomédica en Red-Enfermedades Hepáticas y Digestivas (CIBER-EHD), Barcelona, Spain.
David BernardoGut Immunology Research Group, Instituto de Investigación del Hospital Universitario de la Princesa, Madrid, Spain.
Yolanda Campos-MartínDepartment of Pathology, Hospital Universitario de Toledo, Toledo, Spain.
Elena Martínez-ZamoranoDepartment of Pathology, Hospital Universitario de Toledo, Toledo, Spain.
Diego Muñoz-LópezDepartment of Pathology, Hospital Universitario de Toledo, Toledo, Spain.
Manuel Gómez Del MoralDepartment of Cellular Biology, School of Medicine, Universidad Complutense of Madrid (UCM), Madrid, Spain.
Francisco Javier CuberoDepartment of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
Richard S BlumbergDivision of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Eduardo Martínez-NavesDepartment of Immunology, Ophthalmology and ORL, School of Medicine, Universidad Complutense of Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Madrid, Spain.
Research Institute Hospital 12 de Octubre · ESComplejo Hospitalario Universitario de Toledo · ESHospital Universitario Fundación Jiménez Díaz · ESSpanish National Centre for Cardiovascular Research · ESUniversidade de São Paulo · BRBrigham and Women's Hospital · USCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESCentro de Investigaciones Energéticas, Medioambientales y Tecnológicas · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESSpanish National Cancer Research Centre · ESUniversidad Complutense de Madrid · ESUniversidad de Valladolid · ES

Funding

Endoplasmic reticulum stress and intestinal inflammationR01DK088199 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI Richard S Blumberg · 2010 to 2026
$9.6M
NIDDK NIH HHS R01 DK088199
6 · The paper itself

Abstract

Introduction: The Unfolded Protein Response, a mechanism triggered by the cell in response to Endoplasmic reticulum stress, is linked to inflammatory responses. Our aim was to identify novel Unfolded Protein Response-mechanisms that might be involved in triggering or perpetuating the inflammatory response carried out by the Intestinal Epithelial Cells in the context of Inflammatory Bowel Disease. Methods: We analyzed the transcriptional profile of human Intestinal Epithelial Cell lines treated with an Endoplasmic Reticulum stress inducer (thapsigargin) and/or proinflammatory stimuli. Several genes were further analyzed in colonic biopsies from Ulcerative Colitis patients and healthy controls. Lastly, we generated Caco-2 cells lacking HMGCS2 by CRISPR Cas-9 and analyzed the functional implications of its absence in Intestinal Epithelial Cells. Results: Exposure to a TLR ligand after thapsigargin treatment resulted in a powerful synergistic modulation of gene expression, which led us to identify new genes and pathways that could be involved in inflammatory responses linked to the Unfolded Protein Response. Key differentially expressed genes in the array also exhibited transcriptional alterations in colonic biopsies from active Ulcerative Colitis patients, including NKG2D ligands and the enzyme HMGCS2. Moreover, functional studies showed altered metabolic responses and epithelial barrier integrity in HMGCS2 deficient cell lines. Conclusion: We have identified new genes and pathways that are regulated by the Unfolded Protein Response in the context of Inflammatory Bowel Disease including

Indexed as

Colitis, UlcerativeInflammatory Bowel DiseasesCaco-2 CellsEndoplasmic Reticulum StressEpithelial CellsHumansHydroxymethylglutaryl-CoA SynthaseThapsigarginHMGCS2 protein, humanHydroxymethylglutaryl-CoA SynthaseThapsigarginER stressHMGCS2inflammationinflammatory bowel diseaseunfolded protein response (UPR)

Identifiers

PMID37457727
PMCPMC10348483
OpenAlexW4382776225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.